No Photo Available

Last Update

2016-07-15T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Prior?

Dr. David V. Prior

Executive Vice President Clinical, Regulatory and Scientific Affairs

Innocoll , Inc.

Direct Phone: +44 **** ******       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Innocoll , Inc.

Unit 9 Block D Monksland Business Park

Athlone,

Ireland

Company Description

Innocoll is a global, specialty pharmaceutical company with late stage development programs that is dedicated to engineering better medicines to help patients get better. Our proprietary, biocompatible, and biodegradable collagen products are precision-en ... more

Find other employees at this company (35)

Background Information

Employment History

Technical Director

Pharmaceutical Profiles Ltd

Vice President

Fuisz Media LLC

Education

Ph.D.

physical organic chemistry

University of Surrey

Web References (13 Total References)


Innocoll has a highly experienced Senior Management team

innocollinc.com [cached]

David Prior

Executive Vice President Global Regulatory Affairs
David Prior, Ph.D. has served as Executive Vice President, Clinical, Regulatory and Scientific Affairs since 2008. He has more than 30 years of international experience in the pharmaceutical industry, having worked for major research-based companies, such as Wyeth and Aventis, as well as drug delivery companies, including Elan Corporation and Fuisz Technologies (Biovail). Dr. Prior joined Innocoll in 2004 from the UK-based CRO, Pharmaceutical Profiles, where he served on the board of directors as technical director responsible for R&D, clinical manufacturing and quality assurance. Dr. Prior holds a Ph.D. in physical organic chemistry from the University of Surrey.


Innocoll - CollaRx® & LiquiColl® - biodegradable surgical implants and topically applied healthcare products

www.innocollinc.com [cached]

EXECUTIVE VICE PRESIDENT CLINICAL, REGULATORY AND SCIENTIFIC AFFAIRS: David Prior

David holds a Ph.D. in Physical Organic Chemistry from the University of Surrey. He has more than 25 years international experience in the pharmaceutical industry having worked for major research-based companies such as Wyeth and Aventis, as well as drug delivery companies including Elan Corporation and Fuisz Technologies (Biovail). David joined Innocoll from the UK-based CRO, Pharmaceutical Profiles, where he served on the Board as Technical Director responsible for R&D, Clinical Manufacturing, and Quality Assurance.


Innocoll Inc. - Specializing in the Local Treatment of Pain and Infection

www.innocollinc.com [cached]

David Prior, Ph.D.VP Business Development, Innocoll TechnologiesDavid holds a Ph.D. in Physical Organic Chemistry from the University of Surrey.He has more than 25 years international experience in the pharmaceutical industry having worked for major research-based companies such as Wyeth and Aventis, followed by the drug delivery companies Elan Corporation and Fuisz Technologies (now part of Biovail Corporation).While at Fuisz, David served as Vice President, Pharmaceutical Technologies and Vice President, Scientific Affairs.He joined Innocoll from the UK-based CRO, Pharmaceutical Profiles, where he served on the Board as Technical Director responsible for R&D, clinical manufacturing and Quality Assurance.


Pharmalicensing.com

pharmalicensing.com [cached]

David Prior Vice President Business Development, Innocoll Technologies Request more information


Innocoll to establish R&D and Manufacturing Facility in Ireland

biotechnologyireland.vbnlive.com [cached]

The senior management teamincludes Denise Carter, 36, President, Innocoll Pharmaceuticals ; Joan FitzPatrick, 35, VP Research and Development, Innocoll Technologies; and David Prior, Ph.D., 43, Vice President Business Development, Innocoll Technologies.

Similar Profiles

Other People with this Name

Other people with the name Prior

Monica Prior
Exponential Interactive Inc

Andrew Prior
London Fittings & Flanges Limited

Mathew Prior
J K Williams

John Prior
JADAK Technologies Inc

Gerry Prior
Sallal Water Association

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory